Literature DB >> 26912515

'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?

Sarosh R Irani1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26912515      PMCID： PMC5963431          DOI： 10.1093/brain/awv364

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  14 in total

1.  Seroprevalence of autoantibodies against brain antigens in health and disease.

Authors:  Liane Dahm; Christoph Ott; Johann Steiner; Beata Stepniak; Bianca Teegen; Sandra Saschenbrecker; Christian Hammer; Kathrin Borowski; Martin Begemann; Sandra Lemke; Kristin Rentzsch; Christian Probst; Henrik Martens; Jürgen Wienands; Gianfranco Spalletta; Karin Weissenborn; Winfried Stöcker; Hannelore Ehrenreich
Journal:  Ann Neurol       Date:  2014-06-23       Impact factor: 10.422

2.  Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer.

Authors:  Christian Geis; Benedikt Grünewald; Andreas Weishaupt; Thomas Wultsch; Klaus V Toyka; Andreas Reif; Claudia Sommer
Journal:  J Neural Transm (Vienna)       Date:  2012-02-14       Impact factor: 3.575

3.  Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.

Authors:  Niels Hansen; Benedikt Grünewald; Andreas Weishaupt; Maria Nandini Colaço; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  Exp Neurol       Date:  2012-10-23       Impact factor: 5.330

4.  Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

Authors:  Eric Lancaster; Meizan Lai; Xiaoyu Peng; Ethan Hughes; Radu Constantinescu; Jeffrey Raizer; Daniel Friedman; Mark B Skeen; Wolfgang Grisold; Akio Kimura; Kouichi Ohta; Takahiro Iizuka; Miguel Guzman; Francesc Graus; Stephen J Moss; Rita Balice-Gordon; Josep Dalmau
Journal:  Lancet Neurol       Date:  2009-12-02       Impact factor: 44.182

5.  Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome.

Authors:  C Wessig; R Klein; M F Schneider; K V Toyka; M Naumann; C Sommer
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

6.  Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.

Authors:  K Tanaka; M Tanaka; S Igarashi; O Onodera; T Miyatake; S Tsuji
Journal:  Clin Neurol Neurosurg       Date:  1995-02       Impact factor: 1.876

7.  Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition.

Authors:  Christian Werner; Martin Pauli; Sören Doose; Andreas Weishaupt; Holger Haselmann; Benedikt Grünewald; Markus Sauer; Manfred Heckmann; Klaus V Toyka; Esther Asan; Claudia Sommer; Christian Geis
Journal:  Brain       Date:  2015-11-18       Impact factor: 13.501

8.  Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss.

Authors:  Thashi Chang; Harry Alexopoulos; Philippa Pettingill; Mary McMenamin; Robert Deacon; Ferenc Erdelyi; Gabor Szabó; Camilla J Buckley; Angela Vincent
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 9.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

Review 10.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422
View more
  9 in total

Review 1.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 2.  Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.

Authors:  Farwa Ali; Eelco F Wijdicks
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.532

3.  Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum.

Authors:  Joo Hee Seo; Yun-Jin Lee; Ki Hyeong Lee; Elakkat Gireesh; Holly Skinner; Michael Westerveld
Journal:  Clin Exp Pediatr       Date:  2019-08-16

Review 4.  The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.

Authors:  Valentina Damato; Bettina Balint; Anne-Kathrin Kienzler; Sarosh R Irani
Journal:  Mov Disord       Date:  2018-09-14       Impact factor: 10.338

5.  Further reducing terra incognita on the map of synaptic autoimmunity.

Authors:  Harald Prüss
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-08-02

6.  Involuntary movement in stiff-person syndrome with amphiphysin antibodies: A case report.

Authors:  Yin-Yin Xie; Hong-Mei Meng; Feng-Xiao Zhang; Buajieerguli Maimaiti; Ting Jiang; Yu Yang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

7.  Structural Analysis of Anti-Hapten Antibodies to Identify Long-Range Structural Movements Induced by Hapten Binding.

Authors:  Mohammed M Al Qaraghuli; Karina Kubiak-Ossowska; Valerie A Ferro; Paul A Mulheran
Journal:  Front Mol Biosci       Date:  2021-03-24

Review 8.  Biotherapeutic Antibodies for the Treatment of Head and Neck Cancer: Current Approaches and Future Considerations of Photothermal Therapies.

Authors:  Mohammed M Al Qaraghuli
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

Review 9.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.